Skip to main content

Immunosuppression clinical trials at UCSF
2 in progress, 1 open to new patients

  • Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

    open to eligible people ages 18 years and up

    There is no clear treatment for patients with limited cutaneous Kaposi sarcoma (KS). Radiation and injection of vinblastine both have side effects that may not be acceptable. Nivolumab has been used to treat more extensive KS when given intravenously. This is, to the investigators' knowledge, the first trial to see if nivolumab can be used as treatment in the form of an injection into KS lesion.

    San Francisco, California

  • Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to assess the efficacy of immunosuppression withdrawal (ISW) in pediatric liver transplant (tx) recipients.

    San Francisco, California and other locations